Top

Strahlentherapie und Onkologie

Published in:

12-03-2022 | Hemangioma | Original Article

Radiotherapy for vertebral hemangioma: the single-center experience of 80 patients

Authors: Rahmi Atil Aksoy, Melek Gamze Aksu, Aylin Fidan Korcum, Mine Genc

Published in: Strahlentherapie und Onkologie | Issue 7/2022

Abstract

Purpose

This study aimed to evaluate the therapeutic effect of radiotherapy and to determine possible prognostic factors in patients with painful vertebral hemangioma.

Methods

In the last two decades, 80 patients with vertebral hemangioma who received radiotherapy in our institute were evaluated in terms of pain response, treatment-related side effects, and prognostic factors. All patients were questioned 3 months after radiotherapy for the evaluation of pain response and were divided into three groups (complete response, partial response, and no change). Moreover, the visual analog scale (VAS) was used for pain response assessment in 46 patients. Pain status was assessed to detect recurrence at each clinical examination during the follow-up period. Possible prognostic factors such as gender, size of the hemangioma, location, multilevel involvement and additional musculoskeletal disease on pain response were analyzed.

Results

In this study, 45 individuals had lesions in the lumbar spine, 28 in the thoracic, and 7 in the cervical region. Furthermore, 51 patients had additional musculoskeletal conditions such as disc herniation, degenerative diseases, spondylolisthesis, and compression fracture. Radiotherapy was performed with a median daily dose of 2 Gy and a median total dose of 40 Gy. Complete pain response occurred in 58.8% of patients, 26.2% of patients had partial pain response, and 15% of patients had no pain response. The overall response rate was 85%, and 7 patients showed recurrent pain symptoms in the overall response group at routine follow-up. Additional musculoskeletal disorders were found to be the only prognostic factor associated with pain response. The median follow-up time was 60 months. Secondary malignancy was not found in any of the patients in this short follow-up time. No acute or late radiation-associated side effects greater than grade II were observed.

Conclusion

To our best knowledge, this study is one of the largest single-institution radiotherapy series on vertebral hemangiomas reported to date. The obtained data support the efficacy and safety of radiotherapy in the treatment of painful vertebral hemangioma. Our study showed that additional musculoskeletal disease plays an important role in pain response. Other prognostic factors and treatment of vertebral hemangioma with stereotactic radiosurgery should be investigated in future studies.

Ropper AE, Cahill KS, Hanna JW, McCarthy EF, Gokaslan ZL, Chi JH (2011) Primary vertebral tumors: a review of epidemiologic, histological, and imaging findings. Part I: benign tumors. Neurosurgery 69(6):1171–1180. https://doi.org/10.1227/NEU.0b013e31822b8107CrossRefPubMed

Fox MW, Onofrio BM (1993) The natural history and management of symptomatic and asymptomatic vertebral hemangiomas. J Neurosurg 78(1):36–45. https://doi.org/10.3171/jns.1993.78.1.0036CrossRefPubMed

Pastushyn AI, Slin’ko EI, Mirzoyeva GM (1998) Vertebral hemangiomas: diagnosis, management, natural history and clinicopathological correlates in 86 patients. Surg Neurol 50(6):535–547. https://doi.org/10.1016/s0090-3019(98)00007-xCrossRefPubMed

Dorfman HD, Steiner GC, Jaffe HL (1971) Vascular tumors of bone. Hum Pathol 2(3):349–376. https://doi.org/10.1016/s0046-8177(71)80004-7CrossRefPubMed

Murphey MD, Fairbairn KJ, Parman LM, Baxter KG, Parsa MB, Smith WS (1995) From the archives of the AFIP. Musculoskeletal angiomatous lesions: radiologic-pathologic correlation. Radiographics 15(4):893–891. https://doi.org/10.1148/radiographics.15.4.7569134CrossRefPubMed

Gaudino S, Martucci M, Colantonio R, Lozupone E, Visconti E, Leone A, Colosimo C (2015) A systematic approach to vertebral hemangioma. Skelet Radiol 44(1):25–36. https://doi.org/10.1007/s00256-014-2035-yCrossRef

Laredo JD, Assouline E, Gelbert F, Wybier M, Merland JJ, Tubiana JM (1990) Vertebral hemangiomas: fat content as a sign of aggressiveness. Radiology 177(2):467–472. https://doi.org/10.1148/radiology.177.2.2217787CrossRefPubMed

Vasudeva VS, Chi JH, Groff MW (2016) Surgical treatment of aggressive vertebral hemangiomas. Neurosurg Focus 41(2):E7. https://doi.org/10.3171/2016.5.FOCUS16169CrossRefPubMed

Acosta FL Jr, Sanai N, Chi JH, Dowd CF, Chin C, Tihan T, Chou D, Weinstein PR, Ames CP (2008) Comprehensive management of symptomatic and aggressive vertebral hemangiomas. Neurosurg Clin N Am 19(1):17–29. https://doi.org/10.1016/j.nec.2007.09.010CrossRefPubMed

10.

Sakata K, Hareyama M, Oouchi A, Sido M, Nagakura H, Tamakawa M, Akiba H, Morita K (1997) Radiotherapy of vertebral hemangiomas. Acta Oncol 36(7):719–724. https://doi.org/10.3109/02841869709001344CrossRefPubMed

11.

Piper K, Zou L, Li D, Underberg D, Towner J, Chowdhry AK, Li YM (2020) Surgical management and adjuvant therapy for patients with neurological deficits from vertebral hemangiomas: a meta-analysis. Spine (Phila Pa 1976) 45(2):E99–E110. https://doi.org/10.1097/BRS.0000000000003181CrossRef

12.

Miszczyk L, Tukiendorf A (2012) Radiotherapy of painful vertebral hemangiomas: the single center retrospective analysis of 137 cases. Int J Radiat Oncol Biol Phys 82(2):e173–e180. https://doi.org/10.1016/j.ijrobp.2011.04.028CrossRefPubMed

13.

Mazonakis M, Tzedakis A, Lyraraki E, Damilakis J (2016) Radiation dose and cancer risk to out-of-field and partially in-field organs from radiotherapy for symptomatic vertebral hemangiomas. Med Phys 43(4):1841. https://doi.org/10.1118/1.4944422CrossRefPubMed

14.

Aich RK, Deb AR, Banerjee A, Karim R, Gupta P (2010) Symptomatic vertebral hemangioma: treatment with radiotherapy. J Cancer Res Ther 6(2):199–203. https://doi.org/10.4103/0973-1482.65248CrossRefPubMed

15.

Jiang L, Liu XG, Yuan HS, Yang SM, Li J, Wei F, Liu C, Dang L, Liu ZJ (2014) Diagnosis and treatment of vertebral hemangiomas with neurologic deficit: a report of 29 cases and literature review. Spine J 14(6):944–954. https://doi.org/10.1016/j.spinee.2013.07.450CrossRefPubMed

16.

Faria SL, Schlupp WR, Chiminazzo H Jr (1985) Radiotherapy in the treatment of vertebral hemangiomas. Int J Radiat Oncol Biol Phys 11(2):387–390. https://doi.org/10.1016/0360-3016(85)90162-2CrossRefPubMed

17.

Miszczyk L, Ficek K, Trela K, Spindel J (2001) The efficacy of radiotherapy for vertebral hemangiomas. Neoplasma 48(1):82–84PubMed

18.

Aksu MG, Korcum AF (2009) Symptomatic vertebral hemangioma: results of radiotherapy. J Musculoskelet Pain 16:318–325. https://doi.org/10.1080/10582450802479628CrossRef

19.

Heyd R, Seegenschmiedt MH, Rades D, Winkler C, Eich HT, Bruns F, Gosheger G, Willich N, Micke O, German Cooperative Group on Radiotherapy for Benign Diseases (2010) Radiotherapy for symptomatic vertebral hemangiomas: results of a multicenter study and literature review. Int J Radiat Oncol Biol Phys 77(1):217–225. https://doi.org/10.1016/j.ijrobp.2009.04.055CrossRefPubMed

20.

Rades D, Bajrovic A, Alberti W, Rudat V (2003) Is there a dose-effect relationship for the treatment of symptomatic vertebral hemangioma? Int J Radiat Oncol Biol Phys 55(1):178–181. https://doi.org/10.1016/s0360-3016(02)03734-3CrossRefPubMed

21.

Hall EJ, Giaccia AJ (2012) Radiobiology for the radiologist, 7th edn. Lippincott Williams & Wilkins, Philadelphia

22.

Beyzadeoglu M, Dirican B, Oysul K, Surenkok S, Pak Y (2002) Evaluation of radiation carcinogenesis risk in vertebral hemangioma treated by radiotherapy. Neoplasma 49:338–341PubMed

23.

Yu NY, Sio TT, Lyons MK, Vora SA, Turkmani A, Brown PD, Park SS, Leenstra JL, Bendok BR, Schild SE, Ashman JB (2020) Linear accelerator-based single-fraction stereotactic body radiotherapy for symptomatic vertebral body hemangiomas: The Mayo Clinic experience. J Clin Neurosci 80:74–78. https://doi.org/10.1016/j.jocn.2020.07.060CrossRefPubMed

24.

Zhang M, Chen YR, Chang SD, Veeravagu A (2017) CyberKnife stereotactic radiosurgery for the treatment of symptomatic vertebral hemangiomas: a single-institution experience. Neurosurg Focus 42(1):E13. https://doi.org/10.3171/2016.9.FOCUS16372CrossRefPubMed

Title: Radiotherapy for vertebral hemangioma: the single-center experience of 80 patients
Authors: Rahmi Atil Aksoy
Melek Gamze Aksu
Aylin Fidan Korcum
Mine Genc
Publication date: 12-03-2022
Publisher: Springer Berlin Heidelberg
Keywords: Hemangioma
Hemangioma
Hemangioma
Radiotherapy
Hemangioma
Hemangioma
Published in: Strahlentherapie und Onkologie / Issue 7/2022
Print ISSN: 0179-7158
Electronic ISSN: 1439-099X
DOI: https://doi.org/10.1007/s00066-022-01915-4

Keynote webinar | Spotlight on medication adherence

Springer Medicine

Radiotherapy for vertebral hemangioma: the single-center experience of 80 patients

Abstract

Purpose

Methods

Results

Conclusion

Keynote webinar | Spotlight on medication adherence

Springer Medicine

Abstract

Purpose

Methods

Results

Conclusion

Please log in to get access to this content

Other articles of this Issue 7/2022

Presence of tumour capsule on contrast-enhanced CT is associated with improved outcomes of stereotactic body radiation therapy in hepatocellular carcinoma patients

Whole breast radiotherapy in cN0 early breast cancer patients with pathological sentinel lymph nodes (pN1mic, pN1a) without axillary dissection: preliminary results of the observational LISEN trial

Risk of coronary stenosis after adjuvant radiotherapy for breast cancer

Estimation of secondary cancer projected risk after partial breast irradiation at the 1.5 T MR-linac

37. Jahrestagung der Österreichischen Gesellschaft für Radioonkologie, Radiobiologie und Medizinische Radiophysik

Reply to: Longer treatment time and lower radiation doses—an alternative for Graves’ ophthalmopathy treatment

Estimation of secondary cancer projected risk after partial breast irradiation at the 1.5 T MR-linac